Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| XOMA Corp. | 9 | 0 | 0 | 0 | €26.60 | €98.20 | 269.180% |
| Madrigal Pharmaceuticals inc. | 1 | 0 | 0 | 0 | €489.20 | - | - |
| Pacira Pharmaceuticals | 10 | 0 | 2 | 0 | ? | €29.38 | 45.441% |
| scPharmaceuticals | 3 | 0 | 0 | 0 | €4.80 | €16.51 | 243.875% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €14.71 | - | - |
| Chemed Corp. | 9 | 0 | 1 | 0 | ? | €515.26 | 43.927% |
| Akero Therapeutics Inc | 11 | 2 | 0 | 0 | €47.06 | €68.61 | 45.790% |
| Haemonetics Corp. | 17 | 1 | 1 | 0 | €72.00 | €76.78 | 6.638% |
| Select Medical Holdings | 7 | 0 | 0 | 0 | €12.60 | €21.97 | 74.325% |
| Regeneron Pharmaceuticals Inc. | 37 | 2 | 4 | 0 | €611.60 | €705.36 | 15.330% |
| Celldex Therapeutics | 11 | 2 | 0 | 1 | €25.20 | €42.18 | 67.389% |
| Anthem Inc. | 2 | 0 | 0 | 0 | €277.90 | €450.00 | 61.929% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €111.15 | - | - |
| Corvus Pharmaceuticals Inc | 6 | 0 | 0 | 0 | €7.50 | €10.66 | 42.179% |
| Illumina Inc. | 14 | 6 | 0 | 0 | €110.16 | €110.40 | 0.219% |
| Elanco Animal Health Inc. | 19 | 0 | 2 | 0 | €19.08 | €20.00 | 4.836% |
| Astrazeneca ADR | 1 | 0 | 1 | 0 | €77.50 | €80.00 | 3.226% |
| Theranexus | 2 | 0 | 0 | 0 | ? | €3.00 | 75.953% |
| Alnylam Pharmace. | 51 | 0 | 0 | 0 | €380.80 | €456.30 | 19.825% |
| Amedisys Inc. | 1 | 0 | 0 | 0 | €84.50 | €88.29 | 4.485% |
| Vanda Pharmaceuticals | 13 | 0 | 2 | 0 | €4.68 | €17.30 | 269.692% |
| Cytosorbents Corp. | 12 | 0 | 1 | 0 | €0.63 | €8.73 | 1290.048% |
| Valneva SE | 5 | 0 | 1 | 0 | €3.88 | €5.00 | 28.866% |
| Merit Medical Systems | 31 | 0 | 2 | 0 | ? | €95.59 | 35.590% |
| Incyte Corp. | 15 | 1 | 3 | 0 | €83.32 | €92.79 | 11.366% |